Skip to content
Nobel Jews
Portrait of Salvador E. Luria
Photo: Provided by U.S. National Library of Medicine - please see here for more information., http://profiles.nlm.nih.gov/QL/B/B/K/V/_/qlbbkv_.jpg · Public domain via Wikimedia Commons

Nobel Prize in Physiology or Medicine · 1969

Salvador E. Luria

A refugee from Fascist Italy, he helped prove that bacteria mutate at random, a key to understanding why germs outwit our drugs.

The Nobel citation: “for their discoveries concerning the replication mechanism and the genetic structure of viruses”
Born
August 13, 1912, Turin, Italy
Died
February 6, 1991, Lexington, MA, USA
Shared with
Max Delbrück, Alfred D. Hershey
Affiliation at the time
Massachusetts Institute of Technology (MIT), USA

Medicine prize

1969

Shared with 2 other laureates.

Age that year

57years

Born in 1912.

Headline credited impact

$4.5–6billion in economic value

Cumulative global sales of genetically engineered non-antibody protein medicines (a proxy for economic activity). How it was built

Sources cited

32

Fact-checked September 24, 2026.

  • His key idea came early in 1943, as he watched a colleague hit a slot-machine jackpot at a faculty dance. It led to proof that bacteria mutate at random.
  • As German troops neared Paris in June 1940, he fled south by bicycle and freight train, then sailed from Lisbon to New York.
  • His first graduate student was James Watson, who later worked out the double-helix structure of DNA with Francis Crick.
  • His Nobel Prize was announced the day after he helped organize Boston's Vietnam War Moratorium in October 1969. He pledged part of the prize money to the peace movement.
  • His autobiography is titled A Slot Machine, a Broken Test Tube, after the two chance moments behind his best-known discoveries.

The breakthrough

Proving that bacteria mutate at random, and how viruses copy themselves (1941-1952)

At the time, many scientists were not sure that bacteria had genes at all. When bacteria meet a virus that attacks them, most die, but a few survivors grow into colonies that resist the virus for good. Did the virus somehow teach those few cells to resist? Or had random changes in their genes made a few of them resistant before the virus ever arrived? Early in 1943 Luria found a way to tell, while watching a colleague win a slot-machine jackpot at a faculty dance. A slot machine's payouts are lopsided: usually nothing, sometimes a few coins, and now and then a jackpot. Random mutations should behave the same way. A mutation that strikes early in a growing culture leaves a huge family of resistant descendants, a jackpot; one that strikes late leaves only a few. So Luria grew many small, separate cultures and counted the resistant cells in each. The counts swung wildly, with many zeros and a few jackpots, just as random mutation predicted. Max Delbrück worked out the math, which also gave a way to measure how often genes mutate. With Delbrück and Alfred Hershey, Luria helped work out how bacterial viruses, called phages, multiply and swap genes. In 1952 he and his student Mary Human found that bacteria can block phages grown in other strains, one of the first reports of how bacteria fend off foreign DNA, a line of work that later led to restriction enzymes.[3],[6],[7],[11],[13],[14],[17],[19],[31],[32]

“it dawned on me that slot machines and bacterial mutations have something to teach each other.”
Salvador E. Luria, From his 1984 autobiography, recalling the February 1943 faculty dance at Indiana University where a colleague's jackpot gave him the idea for the fluctuation test. Quoted in the Electronic Scholarly Publishing edition of the 1943 paper.[31]

What it meant for humanity

Luria's experiments helped turn bacteria and their viruses into the workhorses of modern biology. Announcing the prize, the Karolinska Institute credited the three phage pioneers with laying the groundwork of modern molecular biology. The fluctuation test also changed how scientists think about germs that beat our defenses. It showed that resistant bacteria are already present, by chance, before an attack; the attack simply clears away their competitors. Other scientists repeated the test with penicillin and tuberculosis drugs and found the same thing, which implies that bacteria can carry resistance even to antibiotics not yet invented. In 1945-46 Luria himself led a government-funded study of how bacteria resist antibiotics. Cancer researchers later applied the same reasoning to tumors that stop responding to chemotherapy. His 1952 finding that bacteria can block viruses grown in other strains was among the first reports of the bacterial defenses that Werner Arber later explained, work that led to restriction enzymes, the chemical scissors that made gene splicing possible. Genetic engineering in turn gave the world medicines such as human insulin made by bacteria, sold from 1982. Luria also built people and institutions. He trained James Watson, brought Renato Dulbecco into his laboratory, and wrote General Virology (1953), the first comprehensive textbook of the field. As founding director of MIT's Center for Cancer Research, now the Koch Institute, he assembled a group that included David Baltimore and Phillip Sharp, both later Nobel laureates. His book for general readers, Life: The Unfinished Experiment, won the 1974 National Book Award.

  • The 1943 fluctuation test showed that resistance comes from random mutations that arise before any attack. Repeated with penicillin and tuberculosis drugs, it showed germs can carry resistance to drugs they have never met.[6],[13],[17]
  • His 1952 report with Mary Human was among the first descriptions of host-controlled variation, which Werner Arber later traced to restriction enzymes (1978 Nobel Prize). Luria's own case proved to be a related type of bacterial defense.[7],[14],[15],[16],[32]
  • Cancer researchers borrowed his logic. A 1979 model linked a tumor's odds of holding drug-resistant cells to its mutation rate, and a 1983 review weighed the Luria-Delbrück theory's pertinence to chemotherapy.[10],[18],[28]
  • As founding director of MIT's Center for Cancer Research (1972-1985), now the Koch Institute, he led a center whose early scientists included future Nobel laureates David Baltimore and Phillip Sharp.[9],[27]
  • He mentored James Watson, his first graduate student, and wrote General Virology (1953), the field's first comprehensive textbook, later revised with co-authors in 1967 and again in the late 1970s.[5],[11],[12]
  • In 1968, as head of the American Society for Microbiology, he said the society would cut its advisory ties to the US Army's biological laboratory at Fort Detrick, Maryland.[11]

Impact in numbers

Luria's largest contribution is a way of thinking rather than a product. The fluctuation test proved that bacteria have genes that mutate at random, which made microbes a tool of genetics and underpins how scientists understand antibiotic resistance and, by extension, drug resistance in cancer. No study counts the lives that insight saved, so we make no numeric claim for it. We record one conservative ripple claim under the shared recombinant-DNA outcome, using the same total as the Paul Berg, Arthur Kornberg, Joshua Lederberg and François Jacob profiles, and credit him with three tenths of one percent. His 1952 report of host-induced variation was one of several early observations of the phenomenon Werner Arber explained as restriction and modification, and his own system later proved to be a different type of restriction. Arber, Hamilton Smith and Daniel Nathans found and applied the enzymes, and cloning also needed plasmids, other enzymes and industry. His teaching, textbooks and leadership of MIT's cancer center shaped careers and discoveries that also resist pricing.

Fundamental scienceHealthTechnologyEconomyEducation

Each number is the laureate’s credited share of a real-world outcome, cumulative to 2025. The whole outcome, the share of credit, and the reasoning are shown so you can check the arithmetic. Outcomes shared with other laureates are counted once on the impact page.

  • Low confidenceRippleModeledEconomy

    Cumulative global sales of genetically engineered non-antibody protein medicines (a proxy for economic activity)

    $4.5–6

    billion in economic value, credited share

    That is 0.3% of $1.5–2 trillion in economic value since 1982.

    How this number was built

    Same outcome and range as the Berg, Kornberg, Lederberg, Jacob and Lwoff profiles: world sales of recombinant non-antibody protein medicines since Humulin (1982). Inputs: 2013 antibody sales ~$75B were about half of biopharma, so non-antibody ~$75B (Ecker 2015); 2021 non-antibody originators $53.6B, biosimilars $11.1B (Walsh 2022). Low: quadratic ramp 1982-2013 ($0.81T) + linear fall to $53.6B over 2014-21 ($0.50T) + flat 2022-25 ($0.21T) = ~$1.5T. High: linear ramp ($1.2T) + same later years + half of biosimilar sales (~$0.07T) = ~$2.0T. Nominal dollars; sales measure spending, not benefit. Share 0.003 (~$4.5-6B): Luria and Human's 1952 paper is one of four early reports of host-controlled variation cited by Arber, and their system proved to be modification-dependent restriction, not the types Arber and Smith characterized. Others did the rest.[14],[15],[16],[24],[25],[26],[32]

    Sources: Nature Biotechnology (via PubMed Central); mAbs (via PubMed Central); J Community Hosp Intern Med Perspect (via PubMed Central); Journal of Bacteriology (via PubMed Central); NobelPrize.org; NobelPrize.org (Nobel Assembly at Karolinska Institutet); Nucleic Acids Research (via PubMed Central)

The double edge

We found no documented harm caused by Luria's own discoveries. The shadows are indirect or political. His 1952 finding was an early step toward restriction enzymes, and so toward genetic engineering, whose possible risks alarmed scientists and citizens in the 1970s. Luria judged the danger very small but backed citizen oversight of recombinant DNA research in Cambridge, Massachusetts, and was criticized from both sides for that compromise. His outspoken politics also stirred conflict. In 1982 he signed a newspaper advertisement against Israel's invasion of Lebanon, a stand that put him at odds with many American Jewish institutions; three rabbis staged a symbolic excommunication that named him.

  • Minor

    Debate over the risks of gene splicing

    Restriction enzymes, found by researchers studying the kind of bacterial defense he was among the first to report, made gene splicing possible. In the 1970s scientists and Cambridge residents argued over whether such work could release dangerous new organisms. Luria thought the danger very small but supported a citizens' panel to recommend local rules, a compromise that drew fire from activists on one side and fellow scientists on the other.[8],[15],[16],[32]

  • Minor

    A clash with Jewish institutions over Lebanon

    In 1982 he signed a New York Times advertisement opposing Israel's invasion of Lebanon, and his condemnation of Israeli policy set him against many American Jewish institutions. That November three rabbis held a self-styled rabbinic court that 'excommunicated' critics of the war, naming Luria; the head of the Massachusetts Board of Rabbis said the act had little practical validity.[5],[10],[22]

Against the odds

Italy's Jewish community, about 50,000 people in 1933, was one of Europe's oldest and was well integrated. Open antisemitism was relatively rare, and until 1938 Jews could even join the Fascist Party. That year Mussolini's regime, partly under Nazi pressure, began passing racial laws that pushed Jews out of government jobs, public-school teaching, the armed forces and the media, and banned marriages between Jews and non-Jews. Thousands emigrated. Luria felt the change at once. In July 1938 he had just won a government fellowship to study in the United States, and as a Jew he was barred from using it. He moved to Paris and kept working on phage. As German troops neared the city in June 1940, he fled by bicycle and freight train to Marseille, got a US visa, sailed from Lisbon and reached New York on 12 September 1940, by one account with $52. His family stayed in Italy and survived the war. After German forces occupied northern Italy in 1943, they sent 8,564 Jews from Italy and Italian-held lands, including Rhodes and Kos, to the camps, mostly to Auschwitz; 1,009 came back. In America Luria met a different obstacle: suspicion of his left-wing politics. The State Department refused him a passport from 1952 until 1959, and in 1969 his name appeared on an NIH blacklist. Sources tie both to his politics, not his Jewish background.

  • 1938

    Persecution

    In July 1938 Italy awarded him a fellowship for a year of research in the United States, where he hoped to join Max Delbrück. Mussolini's racial campaign began almost at once, and as a Jew he was barred from taking it.[6],[10],[12],[19],[20]

  • 1938

    Exile

    With no future in Italian science, he left for Paris, where a French research fund supported his phage work at the Radium Institute. His family stayed behind in Italy and survived the war.[2],[6],[29]

  • 1940

    War

    As the German army advanced on Paris in June 1940, he fled by bicycle and freight train to Marseille for a US immigration visa, then went on to Lisbon and sailed to New York, arriving on 12 September.[5],[11],[19]

  • 1952

    Other

    After a two-year FBI investigation found no subversive activity, the State Department still refused him a passport in 1952, so he could not lecture in Oxford or visit his mother in Italy. He got a passport only in 1959. The reason was his left-wing politics, not his Jewish background.[10],[11]

  • 1969

    Other

    Days after the Nobel announcement, news broke that the NIH had listed him among scientists kept off its advisory committees, apparently because of his political views.[5],[11],[30]

Jewish background

Both parents JewishIdentified as Jewish, secular

Luria was born in Turin to a Jewish family. His father, Davide, came from an old Sephardic Jewish family; his mother was Ester Sacerdote. Italy's 1938 racial laws cost him a fellowship because he was Jewish, and he left Europe as a Jewish refugee. He married Zella Hurwitz, a daughter of Jewish immigrants from Belarus. No source we found describes religious practice. In 1967 he wrote in Boston's Jewish Advocate, likening Vietnam's war victims to the Jews murdered at Babi Yar. He spoke out for Russian Jews and also condemned Israel's 1982 invasion of Lebanon.[6],[10],[11],[12],[21],[23],[27],[30]

Key dates

  1. August 13, 1912

    Born Salvatore Luria in Turin, Italy, the second son of a Jewish family; his father was an accountant who managed a small printing business.[1],[5],[10],[12]

  2. 1935

    Graduates in medicine from the University of Turin with highest honors, having trained in Giuseppe Levi's histology laboratory.[2],[6],[11]

  3. 1938

    Italy's racial laws cost him a fellowship to study in the United States because he is Jewish. He moves to Paris to study phage at the Radium Institute.[2],[6],[10],[20]

  4. September 12, 1940

    Having fled Paris by bicycle in June as German troops approached, he reaches New York by way of Marseille and Lisbon.[5],[11],[19]

  5. 1943

    At Indiana University he devises the fluctuation test; the Luria-Delbrück paper in Genetics shows that bacteria mutate at random.[6],[13],[31]

  6. January 1947

    Becomes a naturalized US citizen.[2]

  7. 1950

    Moves to the University of Illinois; by his account, Indiana declined to match the offer because of his union and Progressive Party activism.[7],[8]

  8. 1952

    With graduate student Mary Human, reports a host-induced variation of phages, one of the first descriptions of bacterial restriction of viruses.[7],[14],[15],[32]

  9. 1952

    The State Department refuses him a passport over his politics; James Watson presents the latest phage research in Oxford in his place.[11]

  10. 1959

    Joins the Massachusetts Institute of Technology as the first head of its new microbiology program.[2],[5]

  11. 1969

    Shares the Nobel Prize in Physiology or Medicine with Max Delbrück and Alfred Hershey; his Nobel lecture covers his newer work on colicins. Days later, news breaks that he is on an NIH blacklist.[1],[3],[4],[11]

  12. 1972

    Founds MIT's Center for Cancer Research, which opens in 1973 in a former chocolate factory. He directs it until 1985.[9],[10]

  13. 1974

    Wins the National Book Award for Life: The Unfinished Experiment, a biology book for general readers.[9],[10]

  14. February 6, 1991

    Dies in Lexington, Massachusetts, aged 78.[1],[5]

Sources

  1. 1.Salvador E. Luria - Facts · NobelPrize.org (Nobel Prize Outreach)
  2. 2.Salvador E. Luria - Biographical · NobelPrize.org (from Nobel Lectures, Physiology or Medicine 1963-1970), 1969
  3. 3.The Nobel Prize in Physiology or Medicine 1969 - Press release · NobelPrize.org (Karolinska Institutet), 1969
  4. 4.Phage, colicins and macroregulatory phenomena (S. E. Luria, Nobel Lecture, 10 December 1969) · NobelPrize.org, 1969
  5. 5.Biographical Overview - The Salvador E. Luria Papers, Profiles in Science · US National Library of Medicine
  6. 6.Genetics Lessons from Bacteriophage, 1938-1944 - The Salvador E. Luria Papers, Profiles in Science · US National Library of Medicine
  7. 7.From Phage to Colicins, 1945-1972 - The Salvador E. Luria Papers, Profiles in Science · US National Library of Medicine
  8. 8.Politics, Science, and Social Responsibility - The Salvador E. Luria Papers, Profiles in Science · US National Library of Medicine
  9. 9.Later Career: Teacher and Administrator, 1972-1991 - The Salvador E. Luria Papers, Profiles in Science · US National Library of Medicine
  10. 10.LURIA, Salvatore (Federico Di Trocchio), Dizionario Biografico degli Italiani, vol. 66 · Istituto dell'Enciclopedia Italiana (Treccani), 2006
  11. 11.Luria, Salvador Edward (Salvatore) (Rena Selya), Complete Dictionary of Scientific Biography · Charles Scribner's Sons (Gale), via Encyclopedia.com, 2008
  12. 12.In Memoriam: Salvador Edward Luria (1912-1991) (Obaid Siddiqi), Journal of Genetics 70(1):65-68 · Indian Academy of Sciences, 1991
  13. 13.Mutations of Bacteria from Virus Sensitivity to Virus Resistance (Luria SE, Delbrück M), Genetics 28(6):491-511 · Genetics (via PubMed Central), 1943
  14. 14.A Nonhereditary, Host-Induced Variation of Bacterial Viruses (Luria SE, Human ML), Journal of Bacteriology 64(4):557-569 · Journal of Bacteriology (via PubMed Central), 1952
  15. 15.Promotion and Limitation of Genetic Exchange (Werner Arber, Nobel Lecture, 8 December 1978) · NobelPrize.org, 1978
  16. 16.The Nobel Prize in Physiology or Medicine 1978 - Press release · NobelPrize.org (Nobel Assembly at Karolinska Institutet), 1978
  17. 17.Bacteria can develop resistance to drugs they haven't encountered before - scientists figured this out decades ago in a classic experiment (Qi Zheng) · The Conversation, 2024
  18. 18.The forty-year-old mutation theory of Luria and Delbrück and its pertinence to cancer chemotherapy (Skipper HE), Advances in Cancer Research 40:331-363 · Advances in Cancer Research (via PubMed), 1983
  19. 19.Luria & Delbrück: Jackpots and epiphanies (Cristy Gelling) · Genes to Genomes, Genetics Society of America, 2016
  20. 20.Italy - Holocaust Encyclopedia · United States Holocaust Memorial Museum
  21. 21.Dr. Luria, Nobel Prize Winner, Published Article Likening Vietnamese to Jews · Jewish Telegraphic Agency, 1969
  22. 22.A rabbinical leader challenged a move by three conservative rabbis · United Press International, 1982
  23. 23.Review: A Slot Machine, a Broken Test Tube: An Autobiography (S. E. Luria) · Kirkus Reviews
  24. 24.Biopharmaceutical benchmarks 2022 (Walsh G, Walsh E), Nature Biotechnology 40:1722-1760 · Nature Biotechnology (via PubMed Central), 2022
  25. 25.The therapeutic monoclonal antibody market (Ecker DM, Jones SD, Levine HL), mAbs 7(1):9-14 · mAbs (via PubMed Central), 2015
  26. 26.History of insulin (Quianzon CC, Cheikh I), Journal of Community Hospital Internal Medicine Perspectives 2(2) · J Community Hosp Intern Med Perspect (via PubMed Central), 2012
  27. 27.Honoring Salvador Luria, longtime MIT professor and founding director of the MIT Center for Cancer Research (Kate Silverman Wilson) · MIT Department of Biology, 2022
  28. 28.A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate (Goldie JH, Coldman AJ), Cancer Treatment Reports 63(11-12):1727-1733 · Cancer Treatment Reports (via PubMed), 1979
  29. 29.Luria, Salvador Edward (Michael F. Haines), The Scribner Encyclopedia of American Lives · Charles Scribner's Sons (Gale), via Encyclopedia.com
  30. 30.Luria, Salvador Edward (Mordecai L. Gabriel; Rohan Saxena), Encyclopaedia Judaica, 2nd ed. · Macmillan Reference USA (Gale), via Encyclopedia.com, 2007
  31. 31.Mutations of Bacteria from Virus Sensitivity to Virus Resistance (Luria SE, Delbrück M, 1943), ESP edition with introduction by Robert J. Robbins · Electronic Scholarly Publishing Project, 2001
  32. 32.Highlights of the DNA cutters: a short history of the restriction enzymes (Loenen WA, Dryden DT, Raleigh EA, Wilson GG, Murray NE), Nucleic Acids Research 42(1):3-19 · Nucleic Acids Research (via PubMed Central), 2014

Fact-checked on September 24, 2026 by a separate AI fact-checking pass that re-opened the sources, with 8 corrections made. How we check

Suggest a correction